Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humia vs High Hyal Plus in Knee Osteoarthritis
NCT02893098Phase 3Completed
- Sponsor
- Huons
- Start
- Aug 2016
- Primary completion
- Oct 2017
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hyaluronic acid in osteoarthritis (OA) (2 arms), sponsored by Huons. Primary endpoint: Change from baseline of Weight-bearing pain (100mm-VAS) at 14 weeks. Started Aug 2016; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02893098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02893098.